comparemela.com
Latest Breaking News On - Abnormal tau - Page 1 : comparemela.com
Marvel Biosciences Announces Positive Interim Results on Tau Phosphorylation with MB-204
Marvel Biosciences Corp. , and its wholly owned subsidiary, Marvel Biotechnology Inc. , today reported promising interim results from its acute study on MB-204 conducted by Professor Emmanuel Planel.
Mark-williams
Emmanuel-planel
Marvel-biotechnology-inc
Regulation-services-provider
Alberta-newsfile-corp
Laval-university
Marvel-biosciences-corp
Venture-exchange
Company-or-marvel
Marvel-biotechnology
Professor-emmanuel-planel
Abnormal-tau
vimarsana © 2020. All Rights Reserved.